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Our traditional understanding of Darwin’s principle of natural selection is that organisms 8 
become better adapted to the environment they live in. Accordingly, new traits are selected 9 
for because they increase the organisms’ fitness. However, organisms cannot only gain but 10 
also lose traits. How can we understand trait loss in the light of natural selection? Darwin 11 
paid great attention to address this important issue (1). He argued that trait loss occurs 12 
because of disuse: organisms experience environmental changes, which might render 13 
previously beneficial traits useless, and since the maintenance of redundant traits is 14 
conceivable costly, natural selection should favor their degradation. Convincing support for 15 
Darwin’s argument comes from studies on endosymbionts showing that shifts from free-living 16 
to endosymbiotic lifestyles are accompanied by large-scale genome reduction (2). Given this 17 
compelling evidence, one might think that alternative reasons for trait loss are quite 18 
implausible. Certainly, beneficial traits should not be lost, as this would curb the organisms’ 19 
fitness. Yet exactly such scenarios exist, as evidenced by Andersen et al. (3) in their PNAS 20 
paper on evolutionary dynamics of the opportunistic human pathogen Pseudomonas 21 
aeruginosa during chronic lung infections. 22 
 23 
Opportunistic pathogens typically experience drastic changes when colonizing the host from 24 
an environmental reservoir. When infections become chronic, pathogens can evolve within 25 
hosts and adapt to the new environment. Trait loss has been observed in such contexts, and 26 
following Darwin’s logic, such losses have typically been attributed to disuse. However, 27 
Andersen et al. (3) argue that such conclusions are premature if the biological details of the 28 
2 
trait in question are not carefully considered. In their paper, Andersen et al. (3) studied the 29 
loss of pyoverdine production during long-term evolution of P. aeruginosa in cystic fibrosis 30 
lungs. Pyoverdine is a siderophore produced by this bacterium to scavenge insoluble or host-31 
bound iron from the environment (4) (Fig. 1A). In the context of infections, it has been shown 32 
that pyoverdine is essential for bacteria to get hold of this trace element from host tissue (5, 33 
6). But if pyoverdine is essential why is it then often lost during disease progression? 34 
Trapped with Darwin’s disuse argument, the explanation most commonly put forward is that 35 
pyoverdine is no longer needed in chronic lung infections either because: (i) the prevailing 36 
low oxygen availability increases the concentration of readily available ferrous iron (7); (ii) 37 
iron availability is increased due to disease-related tissue damage (8); or (iii) other sources of 38 
iron, bound to citrate and heme, become available, for which P. aeruginosa has specific 39 
receptors for uptake (4).  40 
 41 
Andersen et al. (3) were not convinced by this reasoning and conducted a series of 42 
experiments to contrast the loss-due-to-disuse hypothesis with an alternative evolutionary 43 
scenario, which is based on the idea that competition between strains can drive the loss of 44 
beneficial traits (Fig. 1B+C). This alternative hypothesis rests upon the observation that 45 
pyoverdine enacts its role outside the cell. Pyoverdine-producing individuals must therefore 46 
secrete their siderophores into the extra-cellular environment, thereby creating a public good, 47 
a pool of pyoverdine molecules that can be used by all individuals having the specific 48 
receptor for uptake (9). However, public good production is vulnerable to exploitation by 49 
cheating mutants that no longer produce but still capitalize on the pyoverdine secreted by 50 
others. By refraining from paying the cost of public good production, cheats can enjoy 51 
relative fitness advantages, and might therefore drive the cooperative trait to extinction (9). 52 
This scenario has at least been observed in evolving P. aeruginosa communities under 53 
laboratory conditions.  Does it also represent a realistic scenario to explain trait loss in 54 
infections?  55 
 56 
3 
This is the question Andersen et al. (3) set out to test. The difficulty is how to discern 57 
between the two opposing hypotheses in a complex, uncontrollable environment such as the 58 
cystic fibrosis lung? The elegance of Andersen’s et al. (3) approach resides in its simplicity. 59 
The authors analyzed genome sequences of P. aeruginosa isolates, collected over time from 60 
60 cystic fibrosis patients. For each isolate, they phenotypically assessed its ability to 61 
produce pyoverdine, and scored whether mutations occurred in genes involved in pyoverdine 62 
synthesis and/or uptake. With this approach, Andersen et al. (3) could reconstruct the 63 
evolutionary history of P. aeruginosa within patients, and thereby test the contrasting 64 
predictions of the two hypotheses. The loss-due-to-disuse hypothesis predicts mutations to 65 
accumulate in genes involved in both pyoverdine synthesis and uptake, as any of these 66 
mutations would contribute to the deterioration of the redundant trait, and therefore confer 67 
fitness benefits. Conversely, the loss-due-to-cheating hypothesis predicts that mutations 68 
should exclusively occur in pyoverdine synthesis genes but not in the receptor gene, at least 69 
as long as pyoverdine producers and non-producers co-exist within a patient. This is 70 
because cheats can only spread and exploit producers if they maintain a functional receptor. 71 
 72 
The data yielded strong support for the loss-due-to-cheating hypothesis. Andersen et al. (3) 73 
found that many isolates lost the ability to produce pyoverdine during the course of the 74 
infection, which went along with a significant accumulation of mutations in pvdS, a gene 75 
coding for the sigma factor controlling pyoverdine synthesis. Intriguingly, pyoverdine non-76 
producers kept their receptors intact for several years, as long as producer strains co-existed 77 
in the same patient. Only after producers have vanished altogether, mutations also 78 
accumulated in the receptor gene. These reconstructed evolutionary trajectories combined 79 
with fitness assays, confirming that non-producers can indeed benefit from exogenously 80 
added pyoverdine, strongly suggest that pyoverdine trait loss is driven by cheating and not 81 
disuse in this system. 82 
 83 
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Exciting as these findings are, a key question that immediately arises is whether trait loss 84 
due to cheating is a common phenomenon in natural populations of bacteria or whether the 85 
reported example represents a special case. While no definite answer can be given at this 86 
stage, we certainly know that most bacterial species rely on a broad range of secreted 87 
compounds to scavenge resources from the environment, but also to build up biofilms, to 88 
move across surfaces and to fight competitors (10). Cheats have been shown to arise for 89 
many of these traits in laboratory settings, but also in infectious contexts (11-14). Thus, the 90 
loss of beneficial traits due to strain competition might be far more common then previously 91 
thought, and emerges as a valid alternative to Darwin’s disuse argument.  92 
 93 
A second important aspect to address is whether the understanding of selection pressures 94 
driving trait loss primarily excites evolutionary biologists or whether this phenomenon is of 95 
broader relevance. Or asked differently, why should patients and clinicians care about 96 
whether disease-causing virulence factors are lost due to disuse or cheating? This is a valid 97 
question, because cystic fibrosis is after all a serious disease, and we would hope that 98 
improved understanding of fundamental evolutionary aspects should also benefit patients in 99 
one or the other way. Indeed, there is a bigger scope for Andersen’s et al. (3) findings, 100 
because the loss of beneficial virulence factors due to cheating is expected to compromise 101 
both the harm bacteria can inflict on the host, and the overall fitness of the bacterial collective 102 
(11, 15). In other words, the spreading of cheats should ease the burden of disease. By 103 
demonstrating that cheats can indeed spread in chronic infections, Andersen’s et al. (3) have 104 
now set the foundation for novel antibacterial therapies, such as the modification of the host 105 
environment to accelerate the spread of cheats (16), or the engineering of antibiotic-106 
susceptible cheats, that are introduced into established infections to first replace the 107 
pathogenic bacteria by cheating, and then to be eradicated themselves by antibiotic 108 
treatment (17).  109 
 110 
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To conclude, we can speculate about whether pyoverdine cheat invasion necessarily eases 111 
the burden of disease in cystic fibrosis lungs. This question is far from straightforward to 112 
answer, especially for a versatile pathogen like P. aeruginosa. One complication is that this 113 
bacterium possesses a second siderophore, called pyochelin, which is typically silent when 114 
pyoverdine is produced, but becomes expressed in pyoverdine non-producers (18). Can 115 
pyochelin compensate for the loss of pyoverdine? If so, then the harm to the patient might 116 
not be lowered when pyoverdine cheats spread. Another complication is that P. aeruginosa 117 
can tap other iron resources, such as ferrous iron bound to heme. Indeed, it has been shown 118 
that P. aeruginosa streamlines iron uptake via this channel over evolutionary time in the lung, 119 
an adaptation that coincides with the decline in pyoverdine availability (19). Finally, patients 120 
differ from one another with respect to the disease causing mutation in the CFTR gene, but 121 
also in their overall physiological status (20). Such inter-individual differences could affect 122 
bacterial evolution and potentially explain why pyoverdine was lost in many but not all 123 
patients. Taken together, the enigma on iron acquisition and pathogen evolution in the cystic 124 
fibrosis lung is complex and not yet fully resolved, but Andersen et al. (3) have unraveled a 125 
key piece of the puzzle.  126 
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Fig. 1. (A) Microcolony of P. aeruginosa producing the auto-fluorescent pyoverdine (visible in 176 
the periplasma) to scavenge iron from the environment (image courtesy of Konstanze 177 
Schiessl). This trait is lost during chronic infections in lungs of cystic fibrosis patients. Two 178 
hypotheses have been proposed to explain this loss. Pyoverdine is selected against 179 
because: (B) iron becomes more readily available in the lung and pyoverdine is no longer 180 
needed for uptake; or (C) pyoverdine is still useful, but is exploited by cheating mutants that 181 
no longer produce but capitalize on the publically available pyoverdine secreted by others. 182 
Color code: red = iron, grey = host tissue, orange = pyoverdine, green = pyoverdine 183 
producer, blue = pyoverdine non-producer. 184 
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